Crossmark

Cardiovascular risk assessment in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease

Crossref DOI link: https://doi.org/10.1016/j.medcli.2023.11.032

Published Print: 2024-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García-Mateo, Sandra

Martínez-Domínguez, Samuel J.

Gargallo-Puyuelo, Carla J.

Gallego, Beatriz

Alfambra, Erika

Aso, María C.

Martinez-Micaelo, Neus

Amigó, Nuria

Martínez-García, Javier

Baptista, Pedro M.

Sanz, Borja

Ballesta, Sara

Espinosa, Judith

Tejero, Carlos

Gomollón, Fernando
Funding

Funding for this research was provided by:

GETECCU
License Information

Text and Data Mining valid from 2024-05-01

Text and Data Mining valid from 2024-05-01

stm-asf valid from 2024-05-01

stm-asf valid from 2024-05-01

stm-asf valid from 2024-05-01

stm-asf valid from 2024-05-01

stm-asf valid from 2024-05-01
More Information

This article is maintained by: Elsevier

Article Title: Cardiovascular risk assessment in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2023.11.032

Content Type: article

Copyright: © 2024 Elsevier España, S.L.U. All rights reserved.